| Literature DB >> 31212685 |
Guanghui Yu1, Feifan Wang2, Jing Hu3, Yan Liao4, Xianzhao Liu5.
Abstract
With the advancement of urbanization, the harm caused to human health by PM2.5 pollution has been receiving increasing attention worldwide. In order to increase public awareness and understanding of the damage caused by PM2.5 in the air and gain the attention of relevant management departments, Changsha City is used as the research object, and the environmental quality data and public health data of Changsha City from 2013 to 2017 are used. All-cause death, respiratory death, cardiovascular death, chronic bronchitis, and asthma were selected as the endpoints of PM2.5 pollution health effects, according to an exposure-response coefficient, Poisson regression model, and health-impact-assessment-related methods (the Human Capital Approach, the Willingness to Pay Approach, and the Cost of Illness Approach), assessing the health loss and economic loss associated with PM2.5. The results show that the pollution of PM2.5 in Changsha City is serious, which has resulted in extensive health hazards and economic losses to local residents. From 2013 to 2017, when annual average PM2.5 concentrations fell to 10 μg/m3, the total annual losses from the five health-effect endpoints were $2788.41 million, $2123.18 million, $1657.29 million, $1402.90 million, and $1419.92 million, respectively. The proportion of Gross Domestic Product (GDP) in the current year was 2.69%, 1.87%, 1.34%, 1.04% and 0.93%, respectively. Furthermore, when the concentration of PM2.5 in Changsha City drops to the safety threshold of 10 μg/m3, the number of affected populations and health economic losses can far exceed the situation when it falls to 35 μg/m3, as stipulated by the national secondary standard. From 2013 to 2017, the total loss under the former situation was 1.48 times, 1.54 times, 1.86 times, 2.25 times, and 2.33 times that of the latter, respectively. Among them, all-cause death and cardiovascular death are the main sources of health loss. Taking 2017 as an example, when the annual average concentration dropped to 10 μg/m3, the health loss caused by deaths from all-cause death and cardiovascular disease was 49.16% of the total loss and 35.73%, respectively. Additionally, deaths as a result of respiratory disease, asthma, and chronic bronchitis contributed to 7.31%, 7.29%, and 0.51% of the total loss, respectively. The research results can provide a reference for the formulation of air pollution control policies based on health effects, which is of great significance for controlling air pollution and protecting people's health.Entities:
Keywords: Changsha; PM2.5; exposure–response coefficient; health economic loss
Mesh:
Substances:
Year: 2019 PMID: 31212685 PMCID: PMC6604026 DOI: 10.3390/ijerph16112063
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Changsha municipal administrative division and monitoring site.
Monthly PM2.5 concentration data statistics in 2017.
| Month | Days | Average (μg/m3) | Max (μg/m3) | Min (μg/m3) | Number of Days PM2.5 Was the Primary Pollution Factor |
|---|---|---|---|---|---|
| 1 | 31 | 99 | 284 | 19 | 28 |
| 2 | 28 | 64 | 133 | 22 | 21 |
| 3 | 31 | 49 | 173 | 10 | 13 |
| 4 | 30 | 41 | 65 | 8 | 12 |
| 5 | 31 | 43 | 79 | 14 | 8 |
| 6 | 30 | 25 | 57 | 10 | 2 |
| 7 | 31 | 26 | 65 | 9 | 2 |
| 8 | 31 | 24 | 44 | 10 | 0 |
| 9 | 30 | 35 | 69 | 12 | 3 |
| 10 | 31 | 46 | 135 | 3 | 11 |
| 11 | 30 | 87 | 182 | 26 | 23 |
| 12 | 31 | 89 | 162 | 48 | 28 |
| Total | 365 | 52 | 284 | 3 | 151 |
Figure 2Changsha PM2.5 monthly variation curve from December 2013 to December 2017.
Figure 3The number of days PM2.5 was the primary pollution factor per month in 2017.
Figure 4The number of days in each concentration interval of PM2.5 in each month of 2017.
Figure 5Comparison of PM2.5 annual average concentration and secondary standard in Changsha 2013 to 2017.
Figure 6Comparison of PM2.5 Concentrations in Cities of Hunan Province in 2017.
Exposure–response relationship for each health-effect endpoint.
| Health Effects Endpoints | Exposure–Response Relationship | Author and Year | ||
|---|---|---|---|---|
| Average (β) | Confidence Interval (95% CI) | Standard Error | ||
| All-cause death | 0.27 | (0.08, 0.46) | 0.10 | Qian Xujun [ |
| 0.36 | (0.11, 0.61) | 0.13 | Kan, H.D. [ | |
| 0.4 | (0.22, 0.59) | 0.09 | Feng, L. [ | |
| 0.38 | (0.31, 0.45) | 0.04 | Shang, Y. [ | |
| Respiratory disease death | 0.51 | (0.10, 0.92) | 0.21 | Ge Xiyong [ |
| 0.63 | (0.07, 1.19) | 0.29 | Feng Jianchun [ | |
| 0.31 | (0.10, 0.52) | 0.11 | Zeng Jun [ | |
| 0.22 | (0.03, 0.41) | 0.10 | Qi Ai [ | |
| Cardiovascular disease death | 0.285 | (0.102, 0.468) | 0.09 | Liang Ruiming [ |
| 0.294 | (0.041, 0.548) | 0.13 | Liang Ruiming [ | |
| 0.442 | (0.053, 0.832) | 0.20 | Liang Ruiming [ | |
| 0.55 | (0.23, 0.87) | 0.16 | Qian Xujun [ | |
| 0.63 | (0.35, 0.91) | 0.14 | Feng, L. [ | |
| 0.44 | (0.33, 0.54) | 0.06 | Shang, Y. [ | |
| 0.53 | (0.15, 0.9) | 0.19 | Xie Peng [ | |
| 0.53 | (0.09, 0.97) | 0.22 | Ma, Y.J. [ | |
| Suffering from chronic bronchitis | 1.09 | (1.05, 1.14) | 0.02 | Chen Xian [ |
| 1.01 | (0.37, 1.56) | 0.33 | Huang Desheng [ | |
| 0.45 | (0.13, 0.77) | 0.16 | Rao Li [ | |
| Suffering from asthma | 1.44 | (1.36,1.52) | 0.04 | Chen Xian [ |
| 2.10 | (1.45,2.74) | 0.33 | Xie Peng [ | |
| 1.50 | (1.2,1.7) | 0.15 | Fan Jingchun [ | |
Heterogeneity test and meta-analysis results.
| Health Terminals | I2 |
| Model | Average (%) | 95% CI (%) |
|---|---|---|---|---|---|
| All-cause death | 0 | 0.889 | Fixed | 0.377 | (0.319, 0.445) |
| Respiratory disease death | 0 | 0.649 | Fixed | 0.366 | (0.212, 0.631) |
| Cardiovascular disease death | 0 | 0.758 | Fixed | 0.464 | (0.384, 0.56) |
| Suffering from chronic bronchitis | 47.8 | 0.147 | Random | 1.088 | (1.044, 1.133) |
| Suffering from asthma | 62.6 | 0.069 | Random | 1.552 | (1.331, 1.811) |
Baseline number of health terminals from 2013 to 2017 (unit: person).
| Year | All-Cause Death | Respiratory Disease Death | Cardiovascular Disease Death | Suffering from Chronic Bronchitis | Suffering from Asthma |
|---|---|---|---|---|---|
| 2013 | 56,832 | 5532 | 18,732 | 49,106 | 89,545 |
| 2014 | 38,751 | 5423 | 19,155 | 49,718 | 90,663 |
| 2015 | 35,896 | 5452 | 19,682 | 50,536 | 92,154 |
| 2016 | 33,715 | 5277 | 20,268 | 51,987 | 94,800 |
| 2017 | 34,919 | 5321 | 20,992 | 53,843 | 98,184 |
Excess health effects when PM2.5 drops to 35 μg/m3 and 10 μg/m3 (unit: person).
| Year | All-Cause Death | Respiratory Disease Death | Cardiovascular Disease Death | Suffering from Chronic Bronchitis | Suffering from Asthma | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 35 μg/m3 | 10 μg/m3 | 35 μg/m3 | 10 μg/m3 | 35 μg/m3 | 10 μg/m3 | 35 μg/m3 | 10 μg/m3 | 35 μg/m3 | 10 μg/m3 | |
| 2013 | 8705 | 13,034 | 825 | 1236 | 3466 | 5138 | 25,952 | 8.94 | 58,905 | 130.02 |
| 2014 | 5424 | 8422 | 739 | 1148 | 3245 | 4987 | 25,206 | 8.79 | 57,602 | 127.14 |
| 2015 | 3302 | 6234 | 488 | 922 | 2204 | 4119 | 21,395 | 7.55 | 50,134 | 110.66 |
| 2016 | 2212 | 5046 | 336 | 769 | 1624 | 3666 | 19,425 | 6.87 | 46,162 | 101.89 |
| 2017 | 2168 | 5114 | 321 | 758 | 1592 | 3717 | 19,749 | 7.19 | 47,022 | 103.79 |
Value assessment of health losses when PM2.5 drops to 35 μg/m3 and 10 μg/m3 (unit: million dollars).
| Year | All-Cause Death | Respiratory Disease Death | Cardiovascular Disease Death | Suffering from Chronic Bronchitis | Suffering from Asthma | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 35 μg/m3 | 10 μg/m3 | 35 μg/m3 | 10 μg/m3 | 35 μg/m3 | 10 μg/m3 | 35 μg/m3 | 10 μg/m3 | 35 μg/m3 | 10 μg/m3 | |
| 2013 | 1188.34 | 1779.26 | 112.57 | 168.76 | 473.19 | 701.44 | 6.44 | 8.94 | 97.96 | 130.02 |
| 2014 | 740.48 | 1149.68 | 100.82 | 156.73 | 442.95 | 680.83 | 6.12 | 8.79 | 92.55 | 127.14 |
| 2015 | 450.82 | 851.01 | 66.57 | 125.82 | 300.93 | 562.25 | 4.34 | 7.55 | 66.69 | 110.66 |
| 2016 | 301.96 | 688.77 | 45.93 | 104.91 | 221.70 | 500.45 | 3.27 | 6.87 | 51.00 | 101.89 |
| 2017 | 295.92 | 698.05 | 43.82 | 103.50 | 217.35 | 507.40 | 3.31 | 7.19 | 50.26 | 103.79 |